Epistaxis 2016: national audit of management

Farboud, Amir

doi:10.1017/s002221511700202x

Cited by 34 publications

(25 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…that 51% of patients were on some form of antithrombotic medication. 1 Therefore, the available evidence cannot conclusively be extrapolated to the population of patients routinely treated in clinical practice.…”

Section: Haemostatic Effectmentioning

confidence: 99%

“…

Epistaxis is a common acute disorder, with approximately 25 000 patients presenting to National Health Service (NHS) hospitals every year in the UK. 1 Patients with epistaxis, who fail to respond to simple first aid management, undergo varied treatment from nasal cautery and insertion of intranasal packs to surgery or interventional radiology. These strategies often require admission to hospital and can be associated with pain, infection or necessity for blood transfusion.

…”

mentioning

confidence: 99%

See 1 more Smart Citation

Dissolvable intranasal haemostatic agents for acute epistaxis: A systematic review and meta‐analysis

Milinis

Swords

Hardman

et al. 2021

Clinical Otolaryngology

View full text Add to dashboard Cite

show abstract

Section: Haemostatic Effectmentioning

confidence: 99%

“…

…”

mentioning

confidence: 99%

Dissolvable intranasal haemostatic agents for acute epistaxis: A systematic review and meta‐analysis

Milinis

Swords

Hardman

et al. 2021

Clinical Otolaryngology

View full text Add to dashboard Cite

show abstract

“…During the data collection period of the audit, online data collection was made possible through the use of a REDCap [9] server (https://www.project-redcap.org) hosted in a secure data safe haven which is compliant with ISO27001 security standards. Automatic data validation was performed prior to submission of each case to ensure complete high-quality data were collected.…”

Section: Ent Trainee Collaboration: How We Do Itmentioning

confidence: 99%

ENT audit and research in the era of trainee collaboratives

Smith

Hardman

Ellis

et al. 2018

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Large surgical audits and research projects are complex and costly to deliver, but increasingly surgical trainees are delivering these projects within formal collaboratives and research networks. Surgical trainee collaboratives are now recognised as a valuable part of the research infrastructure, with many perceived benefits for both the trainees and the wider surgical speciality. In this article, we describe the activity of ENT trainee research collaboratives within the UK, and summarise how INTEGRATE, the UK National ENT Trainee Research Network, successfully delivered a national audit of epistaxis management. The prospective audit collected high-quality data from 1826 individuals, representing 94% of all cases that met the inclusion criteria at the 113 participating sites over the 30-day audit period. It is hoped that the audit has provided a template for subsequent high-quality and cost-effective national studies, and we discuss the future possibilities for ENT trainee research collaboratives.

show abstract

“…Indeed, the Epistaxis 2016: national audit of management demonstrated a 30-day mortality rate of 3.4 per cent. 1 In more recent years, well-established standards of care have outlined initial assessment and management protocols for the treatment of patients presenting with epistaxis. 2 Traditionally, these have involved a stepwise approach to management, with interventions including cautery, topical haemostatic agents, the use of non-dissolvable intranasal packs and surgery.…”

Section: Introductionmentioning

confidence: 99%

“…Interestingly, many patients re-present to hospital following initial treatment and discharge, 30-day re-presentation rates of 13–14 per cent have been reported in the literature. 1 , 4 …”

Section: Introductionmentioning

confidence: 99%

Coronavirus disease 2019: changing the future of emergency epistaxis management

et al. 2021

View full text Add to dashboard Cite

Background Acute epistaxis can be a life-threatening airway emergency, requiring in-patient admission. The coronavirus disease 2019 pandemic placed significant strain on hospital resources, and management has shifted towards an out-patient-centred approach. Methods A five-month single-centre retrospective study was undertaken of all epistaxis patients managed by the ENT department. A pre-coronavirus disease 2019 pandemic group was managed with pre-existing guidelines, compared to new guidelines for the coronavirus disease 2019 pandemic group. A telephone survey was performed on out-patients with non-dissolvable packs to assess patient comfort and satisfaction. Results A total of 142 patients were seen. The coronavirus disease 2019 pandemic group had significantly more patients aged over 65 years (p = 0.004), an increased use of absorbable dressings and local haemostatic agents (Nasopore and Surgiflo), and fewer admissions (all p < 0.0005). Rates of re-presentation and morbidity, and length of hospital stay were similar. The telephone survey revealed out-patient management to be efficacious and feasible. Conclusion The coronavirus disease 2019 pandemic has shifted epistaxis management towards local haemostatic agents and out-patient management; this approach is as safe and effective as previously well-established regimens.

show abstract

Epistaxis 2016: national audit of management

Abstract: Audit findings demonstrate a varying alignment with consensus guidance, with explorative analysis countering some previously well-established tenets of management.

Cited by 34 publications

References 12 publications

Dissolvable intranasal haemostatic agents for acute epistaxis: A systematic review and meta‐analysis

Dissolvable intranasal haemostatic agents for acute epistaxis: A systematic review and meta‐analysis

ENT audit and research in the era of trainee collaboratives

Coronavirus disease 2019: changing the future of emergency epistaxis management

Contact Info

Product

Resources

About